Literature DB >> 12168558

AIDS dementia.

David B Clifford1.   

Abstract

AIDS dementia complex is a relatively recently discovered source of cognitive and motor decline, clearly linked to CNS infection by HIV. While this condition is generally subacutely progressive, and leads to death in a short time-span in untreated patients, improvement in function and prognosis may be achieved by application of highly active antiretroviral therapy. Although this therapy is essential, it may also be necessary in the long term to provide additional neuroprotection, blocking secondary mechanisms of neurotoxicity. With current therapy, infection is never completely eradicated, and significant portions of toxicity seem mediated by indirect mechanisms that may continue even during antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12168558     DOI: 10.1016/s0025-7125(02)00005-6

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  6 in total

Review 1.  Neuropsychiatric manifestations of HIV infection and AIDS.

Authors:  Benoit Dubé; Tami Benton; Dean G Cruess; Dwight L Evans
Journal:  J Psychiatry Neurosci       Date:  2005-07       Impact factor: 6.186

Review 2.  Neuroprotective strategies for HIV-1 associated dementia.

Authors:  Huanyu Dou; Jeffrey D Kingsley; R Lee Mosley; Harris A Gelbard; Howard E Gendelman
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 3.  Can humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders?

Authors:  Santhi Gorantla; Howard E Gendelman; Larisa Y Poluektova
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-07       Impact factor: 4.147

4.  HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.

Authors:  Yun Kyung Hahn; Elizabeth M Podhaizer; Kurt F Hauser; Pamela E Knapp
Journal:  Glia       Date:  2012-08-02       Impact factor: 7.452

5.  Bone marrow diffusion measures correlate with dementia severity in HIV patients.

Authors:  A B Ragin; Y Wu; P Storey; B A Cohen; R R Edelman; L G Epstein; S Gartner
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

6.  Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

Authors:  Michael D Bobardt; Patrick Salmon; Lianchun Wang; Jeffrey D Esko; Dana Gabuzda; Milan Fiala; Didier Trono; Bernadette Van der Schueren; Guido David; Philippe A Gallay
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.